Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Multiple myeloma (MM) is a common blood cancer characterized by plasma cell proliferation.
• Therapeutic resistance is a major challenge in managing MM.
• The bone marrow microenvironment plays a critical role in MM pathogenesis and resistance.

Purpose of the Study:

• To review the role of extracellular vesicles (EVs) in multiple myeloma (MM) progression.
• To summarize how EVs contribute to anticancer treatment resistance in MM.
• To discuss potential therapeutic applications of EVs in MM.

Main Methods:

• Literature review of studies on extracellular vesicles and multiple myeloma.
• Analysis of the role of EVs in cell-to-cell communication within the bone marrow.
• Synthesis of current knowledge on EV-mediated mechanisms of therapeutic resistance.

Main Results:

• Extracellular vesicles (EVs) are key mediators of cell-to-cell communication in the bone marrow microenvironment.
• EVs contribute to multiple myeloma (MM) disease progression.
• EVs play a significant role in the development of resistance to anticancer therapies in MM.

Conclusions:

• Extracellular vesicles (EVs) are implicated in multiple myeloma (MM) pathogenesis and therapeutic resistance.
• Targeting EVs presents a promising avenue for novel MM treatment strategies.
• Further research into EV biology could lead to improved MM therapies.